$9.07
+2.1%Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
AVTR โข NYSE
| Avantor, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||||||
-530.2M | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M | 37.8M | -86.9M | -145.3M | -80.7M | 21.6M | |
410.2M | 405.5M | 402.3M | 405.5M | 379.2M | 395.4M | 398.9M | 404.6M | 99.2M | 60.3M | -60.7M | |
7.7M | -46.9M | -172.4M | -69.1M | -17.7M | -87.5M | -106.7M | -139.7M | -323.6M | -30.7M | 500K | |
46.4M | 46.8M | 40.5M | 45.8M | 50.7M | 44.1M | 67.9M | 18.4M | 48.2M | 98.7M | 18.7M | |
888.6M | -323.8M | 261.9M | 96.2M | 83.3M | 441.7M | 142.7M | 97.9M | 81.4M | 36.8M | 18.7M | |
(145M) | (247.8M) | (224.4M) | (256.9M) | (144.7M) | (42.7M) | (112.3M) | (65.6M) | (31.5M) | (28.6M) | (0.0) | |
-198.9M | 47.7M | 16.6M | -321.3M | -114.5M | 19.5M | -186.6M | -93.8M | 72.6M | -11.5M | 32M | |
623.8M | 840.8M | 870M | 843.6M | 953.6M | 929.8M | 354M | 200.5M | -167.5M | 72.9M | 124.6M | |
INVESTING ACTIVITIES | |||||||||||
-128.8M | -148.8M | -146.4M | -133.4M | -111.1M | -61.6M | -51.6M | -37.7M | -25.2M | -29.9M | -20.9M | |
(0.0) | (0.0) | (0.0) | -20.2M | -4B | (0.0) | (0.0) | (0.0) | -6.7B | (0.0) | -14.5M | |
0.0 | 0.0 | 0.0 | 42.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-1.7M | 587.7M | 2.7M | 1.5M | 3.5M | 2.5M | 9.5M | 14.5M | 9.9M | 0.0 | 0.0 | |
-130.5M | (438.9M) | -143.7M | -109.6M | -4.1B | -59.1M | -42.1M | -23.2M | -6.7B | -29.9M | -35.4M | |
FINANCING ACTIVITIES | |||||||||||
-75.6M | -8.6M | -13.7M | -13.2M | 941.2M | 0.0 | 4.2B | 0.0 | 3B | -702.2M | -400K | |
-318.7M | -1.3B | -846M | -620.4M | 2.3B | -738.5M | -1.9B | -149.8M | 6B | 896.9M | -84.2M | |
(0.0) | (0.0) | (0.0) | -32.4M | -64.6M | -64.6M | -31.3M | (0.0) | -1.7B | -158.7M | -2.3M | |
-80.7M | -8.6M | -13.7M | -13.2M | -25.8M | -20.2M | -2.6B | (0.0) | (0.0) | -702.2M | -400K | |
-15.1M | 69.2M | 16M | 17.3M | 41.9M | 20.2M | -3.9M | -20.5M | -341M | -79.5M | -700K | |
-409.4M | -1.3B | -843.7M | -648.7M | 3.2B | -782.9M | -307.8M | -170.3M | 7B | -43.5M | -87.6M | |
CASH FLOW SUMMARY | |||||||||||
19.7M | -21.5M | 8.2M | -15.5M | -13.2M | 12.1M | -2.5M | -7.8M | 1M | -700K | -1.3M | |
103.6M | -23M | -109.2M | 69.8M | 37.9M | 99.9M | 1.6M | -800K | 122.5M | -1.2M | 300K | |
264.7M | 287.7M | 396.9M | 327.1M | 289.2M | 189.3M | 187.7M | 188.5M | 66M | 67.2M | 66.9M | |
368.3M | 264.7M | 287.7M | 396.9M | 327.1M | 289.2M | 189.3M | 187.7M | 188.5M | 66M | 67.2M | |
495M | 692M | 723.6M | 710.2M | 842.5M | 868.2M | 302.4M | 162.8M | -192.7M | 43M | 103.7M |
AVTR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 29, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 23, 2026 | April 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 01, 2026 | March 26, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | May 07, 2026 | 2026 | |
8-K/A 8-K/A 2025 (Amended) N/A | February 25, 2026 | December 17, 2025 | 2025 | |
8-K/A 8-K/A 2025 (Amended) N/A | February 25, 2026 | December 04, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 11, 2026 | February 11, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 11, 2026 | December 31, 2025 | 2025 |
Continue your AVTR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.